Cereno Scientific AB   Report issue

For profit Phase 1
Founded: Molndal Sweden (2012)

Organization Overview

First Clinical Trial
2017
NCT03903302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Cereno Scientific AB